US5721098A
(en)
*
|
1986-01-16 |
1998-02-24 |
The Regents Of The University Of California |
Comparative genomic hybridization
|
AU647741B2
(en)
*
|
1989-12-01 |
1994-03-31 |
Regents Of The University Of California, The |
Methods and compositions for chromosome-specific staining
|
US6025126A
(en)
|
1991-10-28 |
2000-02-15 |
Arch Development Corporation |
Methods and compositions for the detection of chromosomal aberrations
|
US5976790A
(en)
*
|
1992-03-04 |
1999-11-02 |
The Regents Of The University Of California |
Comparative Genomic Hybridization (CGH)
|
JP3645903B2
(ja)
*
|
1992-03-04 |
2005-05-11 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
比較ゲノムハイブリダイゼーション(cgh)
|
US7534567B2
(en)
|
1992-03-04 |
2009-05-19 |
The Regents Of The University Of California |
Detection of nucleic acid sequence differences by comparative genomic hybridization
|
US5472842A
(en)
*
|
1993-10-06 |
1995-12-05 |
The Regents Of The University Of California |
Detection of amplified or deleted chromosomal regions
|
DE4344726C2
(de)
*
|
1993-12-27 |
1997-09-25 |
Deutsches Krebsforsch |
Verfahren zum Nachweis von nicht balanciertem genetischen Material einer Spezies oder zum Nachweis der Genexpression in Zellen einer Spezies
|
US5962332A
(en)
*
|
1994-03-17 |
1999-10-05 |
University Of Massachusetts |
Detection of trinucleotide repeats by in situ hybridization
|
US6472585B1
(en)
|
1994-04-25 |
2002-10-29 |
Genentech, Inc. |
Cardiotrophin-1 defective mouse
|
US7258983B2
(en)
|
1994-04-25 |
2007-08-21 |
Genentech, Inc. |
Cardiotrophin-1 compositions and methods for the treatment of tumor
|
US5807522A
(en)
*
|
1994-06-17 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for fabricating microarrays of biological samples
|
US7323298B1
(en)
*
|
1994-06-17 |
2008-01-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Microarray for determining the relative abundances of polynuceotide sequences
|
US7378236B1
(en)
|
1994-06-17 |
2008-05-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method for analyzing gene expression patterns
|
US5795716A
(en)
|
1994-10-21 |
1998-08-18 |
Chee; Mark S. |
Computer-aided visualization and analysis system for sequence evaluation
|
US5830645A
(en)
|
1994-12-09 |
1998-11-03 |
The Regents Of The University Of California |
Comparative fluorescence hybridization to nucleic acid arrays
|
US5635351A
(en)
*
|
1995-03-14 |
1997-06-03 |
The Regents Of The University Of California |
Genetic gain and loss in gliomas
|
US5690894A
(en)
*
|
1995-05-23 |
1997-11-25 |
The Regents Of The University Of California |
High density array fabrication and readout method for a fiber optic biosensor
|
WO1997005282A2
(en)
*
|
1995-07-28 |
1997-02-13 |
Rijksuniversiteit Groningen |
Methods and materials for determining relative abundance of microorganisms in mixed populations
|
US20040175718A1
(en)
*
|
1995-10-16 |
2004-09-09 |
Affymetrix, Inc. |
Computer-aided visualization and analysis system for sequence evaluation
|
US5801021A
(en)
*
|
1995-10-20 |
1998-09-01 |
The Regents Of The University Of California |
Amplifications of chromosomal region 20q13 as a prognostic indicator in breast cancer
|
US7455964B1
(en)
|
1996-07-15 |
2008-11-25 |
The Hospital For Sick Children |
Genes from the 20q13 amplicon and their uses
|
US7049424B2
(en)
|
1996-07-15 |
2006-05-23 |
The Regents Of The University Of California |
Genes from the 20Q13 amplicon and their uses
|
WO1997018326A1
(en)
*
|
1995-11-13 |
1997-05-22 |
Institut Pasteur |
Ultrahigh resolution comparative nucleic acid hybridization to combed dna fibers
|
EP0815263B1
(de)
*
|
1995-12-22 |
2004-04-21 |
EXACT Sciences Corporation |
Verfahren zur erkennung von klonalen populationen von transformierten zellen in einer genomisch heterogenen zellulären probe
|
US5837196A
(en)
*
|
1996-01-26 |
1998-11-17 |
The Regents Of The University Of California |
High density array fabrication and readout method for a fiber optic biosensor
|
US5776683A
(en)
*
|
1996-07-11 |
1998-07-07 |
California Pacific Medical Center |
Methods for identifying genes amplified in cancer cells
|
US6100029A
(en)
*
|
1996-08-14 |
2000-08-08 |
Exact Laboratories, Inc. |
Methods for the detection of chromosomal aberrations
|
US6300077B1
(en)
|
1996-08-14 |
2001-10-09 |
Exact Sciences Corporation |
Methods for the detection of nucleic acids
|
US6146828A
(en)
*
|
1996-08-14 |
2000-11-14 |
Exact Laboratories, Inc. |
Methods for detecting differences in RNA expression levels and uses therefor
|
US5928870A
(en)
*
|
1997-06-16 |
1999-07-27 |
Exact Laboratories, Inc. |
Methods for the detection of loss of heterozygosity
|
US6203993B1
(en)
|
1996-08-14 |
2001-03-20 |
Exact Science Corp. |
Methods for the detection of nucleic acids
|
US6020137A
(en)
*
|
1996-08-14 |
2000-02-01 |
Exact Laboratories, Inc. |
Methods for the detection of loss of heterozygosity
|
FR2755147B1
(fr)
*
|
1996-10-30 |
1999-01-15 |
Pasteur Institut |
Procede de diagnostic de maladies genetiques par peignage moleculaire et coffret de diagnostic
|
FR2755149B1
(fr)
|
1996-10-30 |
1999-01-15 |
Pasteur Institut |
Procede de diagnostic de maladies genetiques par peignage moleculaire et coffret de diagnostic
|
GB9704054D0
(en)
|
1997-02-27 |
1997-04-16 |
Univ Cambridge Tech |
Assay
|
EP1005653A4
(de)
*
|
1997-03-24 |
2004-05-06 |
Smithkline Beecham Corp |
Verfahren zur herstellung einer subtraktions-bibliothek
|
EP0878552A1
(de)
|
1997-05-13 |
1998-11-18 |
Erasmus Universiteit Rotterdam |
Molekularer Nachweis von chromosomalen Veränderungen
|
US6268136B1
(en)
|
1997-06-16 |
2001-07-31 |
Exact Science Corporation |
Methods for stool sample preparation
|
DE19743301A1
(de)
*
|
1997-09-30 |
1999-04-01 |
Metasystems Hard & Software Gm |
Verfahren zum Vergleich der Kopienzahl von Nukleinsäuresequenzen
|
US20050084875A1
(en)
*
|
1997-10-24 |
2005-04-21 |
University Of Rochester |
Molecular markers for the diagnosis of Alzheimer's disease
|
WO1999023256A1
(en)
*
|
1997-10-30 |
1999-05-14 |
Cold Spring Harbor Laboratory |
Probe arrays and methods of using probe arrays for distinguishing dna
|
AU1627199A
(en)
|
1997-12-02 |
1999-06-16 |
Ozo Diversified Automation, Inc. |
Automated system for chromosome microdissection and method of using same
|
AU761272B2
(en)
*
|
1998-01-12 |
2003-05-29 |
Newbiotics, Inc. |
Compositions and methods for treating cells having double minute DNA
|
US6289229B1
(en)
|
1998-01-20 |
2001-09-11 |
Scimed Life Systems, Inc. |
Readable probe array for in vivo use
|
US6673914B1
(en)
|
1998-01-22 |
2004-01-06 |
John Wayne Cancer Institute |
Human tumor-associated gene
|
DE59913678D1
(de)
*
|
1998-02-16 |
2006-08-31 |
Metasystems Hard & Software Gm |
Verfahren zum Nachweis von Änderungen in Biopolymeren
|
CA2321986A1
(en)
*
|
1998-02-25 |
1999-09-02 |
Sumitomo Electric Industries, Ltd. |
Method of cancer diagnosis based on the detection of chromosome abnormality
|
US6183957B1
(en)
|
1998-04-16 |
2001-02-06 |
Institut Pasteur |
Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria
|
US6979728B2
(en)
|
1998-05-04 |
2005-12-27 |
Baylor College Of Medicine |
Articles of manufacture and methods for array based analysis of biological molecules
|
JP2002513587A
(ja)
|
1998-05-04 |
2002-05-14 |
ダコ エー エス |
染色体異常を検出するための方法およびプローブ
|
US7901887B2
(en)
|
1998-05-09 |
2011-03-08 |
Ikonisys, Inc. |
Automated cancer diagnostic methods using fish
|
EP1078257A4
(de)
|
1998-05-09 |
2007-07-18 |
Iconisys Inc |
Verfahren und apparat für computergestützte diagnose seltener zellen, einschliesslich fetaler zellen
|
US20020001800A1
(en)
*
|
1998-08-14 |
2002-01-03 |
Stanley N. Lapidus |
Diagnostic methods using serial testing of polymorphic loci
|
JP5213202B2
(ja)
*
|
1998-10-28 |
2013-06-19 |
バイシス・インコーポレーテツド |
細胞アレイならびに遺伝障害マーカーの検出および使用方法
|
AU1811400A
(en)
*
|
1998-11-02 |
2000-05-22 |
Brigham And Women's Hospital |
A method for genomic substractive hybridization
|
US20020048752A1
(en)
*
|
1998-11-23 |
2002-04-25 |
Stanley N. Lapidus |
Methods for detecting lower-frequency molecules
|
US6503718B2
(en)
|
1999-01-10 |
2003-01-07 |
Exact Sciences Corporation |
Methods for detecting mutations using primer extension for detecting disease
|
US6280947B1
(en)
|
1999-08-11 |
2001-08-28 |
Exact Sciences Corporation |
Methods for detecting nucleotide insertion or deletion using primer extension
|
US6387618B1
(en)
*
|
1999-03-03 |
2002-05-14 |
The United States Of America As Represented By The Secretary Of The Navy |
Micronucleus assay with genomic DNA hybridization probe and enzymatic color pigment detection
|
US6174681B1
(en)
|
1999-03-05 |
2001-01-16 |
Mayo Foundation For Medical Education And Research |
Method and probe set for detecting cancer
|
US6465182B1
(en)
|
1999-04-29 |
2002-10-15 |
The Regents Of The University Of California |
Comparative fluorescence hybridization to oligonucleotide microarrays
|
WO2001006014A1
(en)
*
|
1999-07-19 |
2001-01-25 |
American Laboratory Technologies, Inc. |
Removing repetitive sequences from dna
|
US6440706B1
(en)
|
1999-08-02 |
2002-08-27 |
Johns Hopkins University |
Digital amplification
|
US6524794B1
(en)
|
1999-10-29 |
2003-02-25 |
Decode Genetics Ehf. |
Identical-by-descent fragment enrichment
|
US6613516B1
(en)
|
1999-10-30 |
2003-09-02 |
Affymetrix, Inc. |
Preparation of nucleic acid samples
|
AU1918100A
(en)
|
1999-11-18 |
2001-05-30 |
Ikonisys Inc. |
Method and apparatus for computer controlled cell based diagnosis
|
ATE271691T1
(de)
*
|
2000-01-12 |
2004-08-15 |
Ventana Med Syst Inc |
Verfahren zum nachweis der effektivität einer krebstherapie
|
KR20080006002A
(ko)
|
2000-01-13 |
2008-01-15 |
제넨테크, 인크. |
신규 Stra6 폴리펩티드
|
US20040014056A1
(en)
*
|
2000-05-02 |
2004-01-22 |
Jorg Hager |
Identification of genetic markers
|
AU2001255518A1
(en)
*
|
2000-06-07 |
2001-12-17 |
Baylor College Of Medicine |
Compositions and methods for array-based nucleic acid hybridization
|
US20050272085A1
(en)
*
|
2000-09-06 |
2005-12-08 |
Hodge Timothy A |
Methods for forensic and congenic screening
|
US7011943B2
(en)
*
|
2000-09-06 |
2006-03-14 |
Transnetyx, Inc. |
Method for detecting a designated genetic sequence in murine genomic DNA
|
US20050239125A1
(en)
*
|
2000-09-06 |
2005-10-27 |
Hodge Timothy A |
Methods for genotype screening
|
US20030087286A1
(en)
*
|
2000-09-06 |
2003-05-08 |
Hodge Timothy A. |
Isolation of eukaryotic genomic DNA using magnetically responsive solid functionalized particles
|
US7494817B2
(en)
*
|
2000-09-06 |
2009-02-24 |
Transnet Yx, Inc. |
Methods for genotype screening using magnetic particles
|
US20050266494A1
(en)
*
|
2000-09-06 |
2005-12-01 |
Hodge Timothy A |
System and method for computer network ordering of biological testing
|
US20030082605A1
(en)
*
|
2000-09-06 |
2003-05-01 |
Hodge Timothy A. |
Genomic DNA detection method and system thereof
|
WO2002044411A1
(en)
*
|
2000-12-01 |
2002-06-06 |
Rosetta Inpharmatics, Inc. |
Use of profiling for detecting aneuploidy
|
US20020142305A1
(en)
*
|
2001-03-27 |
2002-10-03 |
Koei Chin |
Methods for diagnosing and monitoring ovarian cancer by screening gene copy numbers
|
US20040161741A1
(en)
*
|
2001-06-30 |
2004-08-19 |
Elazar Rabani |
Novel compositions and processes for analyte detection, quantification and amplification
|
US20060014186A1
(en)
*
|
2001-09-04 |
2006-01-19 |
Hodge Timothy A |
Methods for genotype screening of a strain disposed on an adsorbent carrier
|
US7439346B2
(en)
|
2001-10-12 |
2008-10-21 |
Perkinelmer Las Inc. |
Nucleic acids arrays and methods of use therefor
|
US7335470B2
(en)
*
|
2001-10-12 |
2008-02-26 |
Perkinelmer, Las, Inc. |
Compilations of nucleic acids and arrays and methods of using them
|
US20030082618A1
(en)
*
|
2001-10-15 |
2003-05-01 |
Guangshan Li |
Methods for detecting genetic aberrations
|
AU2002352799A1
(en)
*
|
2001-11-20 |
2003-06-10 |
Oncomedx, Inc. |
Methods for evaluating drug-resistance gene expression in the cancer patient
|
US20030124542A1
(en)
*
|
2001-12-28 |
2003-07-03 |
Spectral Genomics, Inc. |
Methods for mapping the chromosomal loci of genes expressed by a cell
|
US6916621B2
(en)
|
2002-03-27 |
2005-07-12 |
Spectral Genomics, Inc. |
Methods for array-based comparitive binding assays
|
JP2005522224A
(ja)
*
|
2002-04-12 |
2005-07-28 |
キュアレイターズ オブ ザ ユニバーシティー オブ ミズーリ |
Dnaの高メチル化と遺伝子サイレンシングの両方をスクリーニングするためのecistマイクロアレイと、そのecistマイクロアレイを利用して遺伝子の発現、dnaのメチル化、ヒストンのアセチル化を評価するための統合システム
|
EP1573056A4
(de)
*
|
2002-05-17 |
2007-11-28 |
Nugen Technologies Inc |
Verfahren zur fragmentierung, markierung und immobilisierung von nukleinsäuren
|
CA2486252C
(en)
|
2002-06-07 |
2012-07-24 |
Genentech, Inc. |
Methods for screening for agents that modulate hepatocellular carcinoma development
|
US9388459B2
(en)
|
2002-06-17 |
2016-07-12 |
Affymetrix, Inc. |
Methods for genotyping
|
NL1021160C2
(nl)
*
|
2002-07-26 |
2004-01-27 |
Multigen Internat B V |
Werkwijze voor het bepalen van het kopieaantal van een nucleotidevolgorde.
|
US7011949B2
(en)
*
|
2002-09-30 |
2006-03-14 |
Agilent Technologies, Inc. |
Methods and compositions for producing labeled probe nucleic acids for use in array based comparative genomic hybridization applications
|
US7822555B2
(en)
|
2002-11-11 |
2010-10-26 |
Affymetrix, Inc. |
Methods for identifying DNA copy number changes
|
AU2003291481A1
(en)
*
|
2002-11-11 |
2004-06-03 |
Affymetrix, Inc. |
Methods for identifying dna copy number changes
|
US10229244B2
(en)
*
|
2002-11-11 |
2019-03-12 |
Affymetrix, Inc. |
Methods for identifying DNA copy number changes using hidden markov model based estimations
|
ES2246748T1
(es)
*
|
2002-12-23 |
2006-03-01 |
Agilent Technologies, Inc. |
Ensayos de hibridacion genomica comparativos que utilizan caracteristicas oligonucleotidicas inmovilizadas y composiciones para ponerlos en practica.
|
US7750908B2
(en)
|
2003-04-04 |
2010-07-06 |
Agilent Technologies, Inc. |
Focus plus context viewing and manipulation of large collections of graphs
|
US20040219532A1
(en)
*
|
2003-04-30 |
2004-11-04 |
Sampson Jeffrey R. |
Internal references measurements
|
AU2004280531B2
(en)
*
|
2003-05-23 |
2010-03-25 |
Cold Spring Harbor Laboratory |
Counting exact word matches in genomes
|
US7211384B2
(en)
*
|
2003-05-28 |
2007-05-01 |
Agilent Technologies, Inc. |
Comparative genomic hybridization assays using immobilized oligonucleotide targets with initially small sample sizes and compositions for practicing the same
|
CA2534441A1
(en)
*
|
2003-08-01 |
2005-02-10 |
Spectral Genomics, Inc. |
Arrays, methods and kits for preparation and use of syntenic genomic arrays for diagnostics and toxicology
|
US20070212689A1
(en)
*
|
2003-10-30 |
2007-09-13 |
Bianchi Diana W |
Prenatal Diagnosis Using Cell-Free Fetal DNA in Amniotic Fluid
|
WO2005065321A2
(en)
|
2003-12-29 |
2005-07-21 |
Nugen Technologies, Inc. |
Methods for analysis of nucleic acid methylation status and methods for fragmentation, labeling and immobilization of nucleic acids
|
US20060084067A1
(en)
*
|
2004-02-03 |
2006-04-20 |
Zohar Yakhini |
Method and system for analysis of array-based, comparative-hybridization data
|
WO2005079474A2
(en)
|
2004-02-17 |
2005-09-01 |
The Regents Of The University Of California |
Detection of nucleic acid sequence differences by comparative genomic hybridization
|
US8321138B2
(en)
|
2005-07-29 |
2012-11-27 |
Agilent Technologies, Inc. |
Method of characterizing quality of hybridized CGH arrays
|
US20070031883A1
(en)
*
|
2004-03-04 |
2007-02-08 |
Kincaid Robert H |
Analyzing CGH data to identify aberrations
|
US20050233339A1
(en)
*
|
2004-04-20 |
2005-10-20 |
Barrett Michael T |
Methods and compositions for determining the relationship between hybridization signal of aCGH probes and target genomic DNA copy number
|
US20050233338A1
(en)
*
|
2004-04-20 |
2005-10-20 |
Barrett Michael T |
Methods and compositions for assessing chromosome copy number
|
CA2567627C
(en)
|
2004-05-20 |
2014-09-30 |
Quest Diagnostics Investments Incorporated |
Single label comparative hybridization
|
CA2572176A1
(en)
*
|
2004-06-21 |
2006-01-05 |
Nimblegen Systems, Inc. |
Probe optimization methods
|
JP4476050B2
(ja)
*
|
2004-06-30 |
2010-06-09 |
株式会社ニデック |
視野計
|
CA2577741A1
(en)
*
|
2004-08-18 |
2006-03-02 |
Abbott Molecular, Inc. |
Determining data quality and/or segmental aneusomy using a computer system
|
US20070099227A1
(en)
*
|
2004-10-12 |
2007-05-03 |
Curry Bo U |
Significance analysis using data smoothing with shaped response functions
|
US20060080043A1
(en)
*
|
2004-10-12 |
2006-04-13 |
Sampas Nicholas M |
Comparative genomic hybridization significance analysis using data smoothing with shaped response functions
|
US20060078898A1
(en)
*
|
2004-10-12 |
2006-04-13 |
Curry Bo U |
Methods and compositions for reducing label variation in array-based comparative genome hybridization assays II
|
US20060078899A1
(en)
*
|
2004-10-12 |
2006-04-13 |
Scheffer Alicia F |
Methods and compositions for reducing label variation in array-based comparative genome hybridization assays
|
US9109256B2
(en)
|
2004-10-27 |
2015-08-18 |
Esoterix Genetic Laboratories, Llc |
Method for monitoring disease progression or recurrence
|
US20060110744A1
(en)
*
|
2004-11-23 |
2006-05-25 |
Sampas Nicolas M |
Probe design methods and microarrays for comparative genomic hybridization and location analysis
|
DE602006018861D1
(de)
|
2005-01-27 |
2011-01-27 |
Quest Diagnostics Invest Inc |
Schnelle komparative genomhybridisierung
|
US20060172314A1
(en)
*
|
2005-01-31 |
2006-08-03 |
Song Min-Sun |
Quantification of amplified nucleic acids
|
US7541144B2
(en)
*
|
2005-01-31 |
2009-06-02 |
Agilent Technologies, Inc. |
RNA labeling method
|
US20060173635A1
(en)
*
|
2005-02-01 |
2006-08-03 |
Yakhini Zohar H |
Analyzing and visualizing enrichment in DNA sequence alterations
|
US20060192570A1
(en)
*
|
2005-02-15 |
2006-08-31 |
Mann & Hummel Gmbh |
Apparatus for monitoring consumable parts
|
JP5744371B2
(ja)
*
|
2005-02-22 |
2015-07-08 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
脊髄小脳性運動失調5型に関する遺伝子の同定、及び使用方法。
|
US9777314B2
(en)
|
2005-04-21 |
2017-10-03 |
Esoterix Genetic Laboratories, Llc |
Analysis of heterogeneous nucleic acid samples
|
US7544471B2
(en)
|
2005-07-30 |
2009-06-09 |
Agilent Technologies, Inc. |
Preparing RNA from a wax-embedded tissue specimen
|
US20070048743A1
(en)
*
|
2005-08-26 |
2007-03-01 |
Sampas Nicholas M |
Methods and compositions for assessing candidate aCGH probe nucleic acids
|
US20070087355A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Barrett Michael T |
Comparative genomic hybridization assays and compositions for practicing the same
|
US8076074B2
(en)
|
2005-11-29 |
2011-12-13 |
Quest Diagnostics Investments Incorporated |
Balanced translocation in comparative hybridization
|
US11306351B2
(en)
|
2005-12-21 |
2022-04-19 |
Affymetrix, Inc. |
Methods for genotyping
|
US20070231803A1
(en)
*
|
2006-03-31 |
2007-10-04 |
Jensen Mark A |
Multiplex pcr mixtures and kits containing the same
|
US20070238106A1
(en)
*
|
2006-04-07 |
2007-10-11 |
Agilent Technologies, Inc. |
Systems and methods of determining alleles and/or copy numbers
|
US20070238104A1
(en)
*
|
2006-04-07 |
2007-10-11 |
Agilent Technologies, Inc. |
Competitive oligonucleotides
|
US8058055B2
(en)
|
2006-04-07 |
2011-11-15 |
Agilent Technologies, Inc. |
High resolution chromosomal mapping
|
US20070238108A1
(en)
*
|
2006-04-07 |
2007-10-11 |
Agilent Technologies, Inc. |
Validation of comparative genomic hybridization
|
US20070259347A1
(en)
*
|
2006-05-03 |
2007-11-08 |
Agilent Technologies, Inc. |
Methods of increasing the effective probe densities of arrays
|
US20080058218A1
(en)
*
|
2006-05-03 |
2008-03-06 |
Gordon David B |
Arrays of compound probes and methods using the same
|
US20070259346A1
(en)
*
|
2006-05-03 |
2007-11-08 |
Agilent Technologies, Inc. |
Analysis of arrays
|
US20070259344A1
(en)
*
|
2006-05-03 |
2007-11-08 |
Agilent Technologies, Inc. |
Compound probes and methods of increasing the effective probe densities of arrays
|
US10522240B2
(en)
|
2006-05-03 |
2019-12-31 |
Population Bio, Inc. |
Evaluating genetic disorders
|
US20070259345A1
(en)
*
|
2006-05-03 |
2007-11-08 |
Agilent Technologies, Inc. |
Target determination using compound probes
|
US7702468B2
(en)
|
2006-05-03 |
2010-04-20 |
Population Diagnostics, Inc. |
Evaluating genetic disorders
|
US7437249B2
(en)
|
2006-06-30 |
2008-10-14 |
Agilent Technologies, Inc. |
Methods and systems for detrending signal intensity data from chemical arrays
|
WO2008005459A2
(en)
*
|
2006-06-30 |
2008-01-10 |
Nugen Technologies, Inc. |
Methods for fragmentation and labeling of nucleic acids
|
US7943310B2
(en)
|
2006-08-30 |
2011-05-17 |
Centocor Ortho Biotech Inc. |
Methods for assessing response to therapy in subjects having ulcerative colitis
|
US7881876B2
(en)
|
2006-10-12 |
2011-02-01 |
Agilent Technologies, Inc. |
Methods and systems for removing offset bias in chemical array data
|
US8077951B2
(en)
|
2006-10-12 |
2011-12-13 |
Agilent Technologies, Inc. |
Method and system for dynamic, automated detection of outlying feature and feature background regions during processing of data scanned from a chemical array
|
US20080090236A1
(en)
*
|
2006-10-13 |
2008-04-17 |
Yakhini Zohar H |
Methods and systems for identifying tumor progression in comparative genomic hybridization data
|
US20080102453A1
(en)
*
|
2006-10-31 |
2008-05-01 |
Jayati Ghosh |
Methods and systems and analysis of CGH data
|
WO2008102606A1
(ja)
|
2007-01-31 |
2008-08-28 |
Wako Pure Chemical Industries, Ltd. |
ゲノムdna断片の増幅または欠失の検出方法
|
US20080241829A1
(en)
*
|
2007-04-02 |
2008-10-02 |
Milligan Stephen B |
Methods And Kits For Producing Labeled Target Nucleic Acid For Use In Array Based Hybridization Applications
|
US8200440B2
(en)
|
2007-05-18 |
2012-06-12 |
Affymetrix, Inc. |
System, method, and computer software product for genotype determination using probe array data
|
US20080293589A1
(en)
*
|
2007-05-24 |
2008-11-27 |
Affymetrix, Inc. |
Multiplex locus specific amplification
|
US7507539B2
(en)
|
2007-07-30 |
2009-03-24 |
Quest Diagnostics Investments Incorporated |
Substractive single label comparative hybridization
|
GB0715030D0
(en)
*
|
2007-08-02 |
2007-09-12 |
Wilson Carol J |
Testing process
|
CA2639530A1
(en)
*
|
2007-09-17 |
2009-03-17 |
Bassem Bejjani |
Methods and systems for the detection of microdeletion and microduplication syndromes
|
EP2195454A4
(de)
*
|
2007-09-28 |
2011-08-24 |
Murdoch Childrens Res Inst |
Zellnachweis, überwachung und isolierungsverfahren
|
US20090088330A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Leproust Emily M |
Methods And Kits For Producing Labeled Target Nucleic Acids For Use In Array Based Hybridization Applications
|
US8093063B2
(en)
|
2007-11-29 |
2012-01-10 |
Quest Diagnostics Investments Incorporated |
Assay for detecting genetic abnormalities in genomic nucleic acids
|
US7964354B2
(en)
|
2007-12-20 |
2011-06-21 |
Celgene Corporation |
Use of micro-RNA as a biomarker of immunomodulatory drug activity
|
BRPI0917379A2
(pt)
|
2008-08-29 |
2015-11-17 |
Centocor Ortho Biotech Inc |
marcadores e metodos para avaliar e tratar colite ulcerativa e desordens relacionadas usando um painel de 20 genes
|
US20100104513A1
(en)
*
|
2008-10-28 |
2010-04-29 |
General Electric Company |
Method and system for dye assessment
|
AU2009313999B2
(en)
*
|
2008-11-12 |
2016-09-29 |
Lineagen, Inc. |
Autism associated genetic markers
|
JP5645816B2
(ja)
|
2009-05-25 |
2014-12-24 |
国立大学法人東京工業大学 |
中枢神経細胞の増殖及び分化に係る中核因子を含む医薬組成物
|
US20120141472A1
(en)
|
2009-05-29 |
2012-06-07 |
Shalini Singh |
Methods of scoring gene copy number in a biological sample using in situ hybridization
|
WO2010138908A1
(en)
|
2009-05-29 |
2010-12-02 |
Ventana Medical Systems, Inc. |
Igfir gene copy number as a prognostic marker in a non-small cell lung cancer
|
CN102630250A
(zh)
|
2009-09-25 |
2012-08-08 |
基因诊断测试公司 |
用于检测与癌症和其他疾病相关的染色体异常的多重(+/-)链阵列和测试
|
EP2491141A2
(de)
|
2009-10-19 |
2012-08-29 |
Stichting Het Nederlands Kanker Instituut |
Differenzierung zwischen brca2-tumoren und sporadischen tumoren mittels array-basierter vergleichender genomhybridisierung
|
US20120322677A1
(en)
|
2009-10-19 |
2012-12-20 |
Stichting Het Nederlands Kanker Instituut |
Predicting benefit of anti-cancer therapy via array comparative genomic hybridization
|
US20120277112A1
(en)
|
2009-10-19 |
2012-11-01 |
Stichting Het Nederlands Kanker Instituut |
Predicting response to anti-cancer therapy via array comparative genomic hybridization
|
CA2778005A1
(en)
|
2009-10-26 |
2011-05-12 |
Abbott Laboratories |
Detection of chromosomal abnormalities associated with prognosis of non small cell lung cancer
|
CA2785656A1
(en)
|
2009-12-29 |
2011-07-07 |
Cancer Genetics, Inc. |
Tool for diagnosis and prognosis of mature b-cell neoplasms
|
EP2519647A1
(de)
|
2009-12-31 |
2012-11-07 |
Ventana Medical Systems, Inc. |
Verfahren zur herstellung von eindeutig spezifischen nukleinsäuresonden
|
EP2521794B1
(de)
|
2010-01-08 |
2015-08-12 |
Oxford Gene Technology (Operations) Ltd |
Kombiniertes cgh und allelspezifisches hybridisierungsverfahren
|
US8774488B2
(en)
|
2010-03-11 |
2014-07-08 |
Cellscape Corporation |
Method and device for identification of nucleated red blood cells from a maternal blood sample
|
ES2621812T3
(es)
|
2010-05-10 |
2017-07-05 |
Mayo Foundation For Medical Education And Research |
Detección de anomalías cromosómicas asociadas con el cáncer endometrial
|
ES2692152T3
(es)
|
2010-06-15 |
2018-11-30 |
Celgene Corporation |
Biomarcadores para el tratamiento de la psoriasis
|
US20120046877A1
(en)
*
|
2010-07-06 |
2012-02-23 |
Life Technologies Corporation |
Systems and methods to detect copy number variation
|
US8862410B2
(en)
|
2010-08-02 |
2014-10-14 |
Population Diagnostics, Inc. |
Compositions and methods for discovery of causative mutations in genetic disorders
|
US20140018251A1
(en)
|
2010-09-20 |
2014-01-16 |
Stichting Het Nederlands Kanker Instituut |
Methods for Predicting Response to Anti-Cancer Therapy in Cancer Patients
|
AU2012249491B2
(en)
|
2011-04-29 |
2016-12-15 |
Celgene Corporation |
Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
|
WO2013007808A1
(en)
|
2011-07-14 |
2013-01-17 |
Traslational Cancer Drugs Pharma, S.L. |
Method for predicting outcome of cancer in a subject
|
US20130078632A1
(en)
|
2011-09-23 |
2013-03-28 |
Academisch Medisch Centrum |
Materials and methods for prognosis of progression of barrett's esophagus
|
US10221454B2
(en)
|
2011-10-10 |
2019-03-05 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
US10378060B2
(en)
|
2011-10-14 |
2019-08-13 |
Dana-Farber Cancer Institute, Inc. |
ZNF365/ZFP365 biomarker predictive of anti-cancer response
|
CA2852949A1
(en)
|
2011-10-19 |
2013-04-25 |
Nugen Technologies, Inc. |
Compositions and methods for directional nucleic acid amplification and sequencing
|
US9121051B2
(en)
|
2011-10-31 |
2015-09-01 |
Arkray, Inc. |
Method of determining the abundance of a target nucleotide sequence of a gene of interest
|
DK2773779T3
(da)
|
2011-11-04 |
2020-11-23 |
Population Bio Inc |
Fremgangsmåder og sammensætninger til diagnosticering, prognose og forebyggelse af neurologiske tilstande
|
TWI455461B
(zh)
*
|
2011-11-23 |
2014-10-01 |
Delta Electronics Inc |
冷卻套
|
JP2015500035A
(ja)
|
2011-12-10 |
2015-01-05 |
アボツト・モレキユラー・インコーポレイテツド |
悪性黒色腫の診断および悪性黒色腫の転移の予後予測のための物質および方法
|
KR101917272B1
(ko)
|
2011-12-22 |
2018-11-09 |
쌩뜨레 나티오날 데 라 르세르쉬 생띠끄 (씨. 엔. 알. 에스) |
단일-분자 혼성화 및 조작에 의한 dna 검출 및 정량화의 방법
|
WO2013101613A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Molecular Inc. |
Materials and methods for diagnosis, prognosis, monitoring of recurrence, and assessment of therapeutic/prophylactic treatment of pancreatobiliary cancer
|
WO2013101611A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Molecular Inc. |
Materials and methods for diagnosis of bladder cancer and monitoring recurrence thereof
|
ES2633183T3
(es)
|
2011-12-30 |
2017-09-19 |
Abbott Molecular Inc. |
Materiales y procedimientos para el diagnóstico, pronóstico y evaluación del tratamiento terapéutico/profiláctico del cáncer de próstata
|
EP2807292B1
(de)
|
2012-01-26 |
2019-05-22 |
Tecan Genomics, Inc. |
Zusammensetzungen und verfahren zur gezielten nukleinsäuresequenzanreicherung und erzeugung einer hocheffizienten bibliothek
|
US10407724B2
(en)
|
2012-02-09 |
2019-09-10 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
WO2013124740A2
(en)
|
2012-02-23 |
2013-08-29 |
Stichting Vu-Vumc |
BRCA DEFICIENCY PROTEIN AND mRNA SIGNATURES USEFUL IN IDENTIFICATION OF PATIENTS WITH BRCA-DEFICIENT TUMORS AND PREDICTING BENEFIT OF ANTI-CANCER THERAPY IN CANCER PATIENTS
|
WO2013167387A1
(en)
|
2012-05-10 |
2013-11-14 |
Ventana Medical Systems, Inc. |
Uniquely specific probes for pten, pik3ca, met, top2a, and mdm2
|
ITMI20120846A1
(it)
|
2012-05-16 |
2013-11-17 |
Bongulielmi Reto |
Metodo e sistema per valutare molecole in campioni biologici tramite immagini derivate da microarray
|
WO2013191775A2
(en)
|
2012-06-18 |
2013-12-27 |
Nugen Technologies, Inc. |
Compositions and methods for negative selection of non-desired nucleic acid sequences
|
CA2877736C
(en)
|
2012-06-29 |
2021-12-07 |
Celgene Corporation |
Methods for determining drug efficacy using cereblon-associated proteins
|
US20150011396A1
(en)
|
2012-07-09 |
2015-01-08 |
Benjamin G. Schroeder |
Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
|
US9587281B2
(en)
|
2012-08-14 |
2017-03-07 |
Celgene Corporation |
Cereblon isoforms and their use as biomarkers for therapeutic treatment
|
DK2895621T3
(da)
|
2012-09-14 |
2020-11-30 |
Population Bio Inc |
Fremgangsmåder og sammensætning til diagnosticering, prognose og behandling af neurologiske tilstande
|
WO2014048942A1
(en)
|
2012-09-25 |
2014-04-03 |
Ventana Medical Systems, Inc. |
Probes for pten, pik3ca, met, and top2a, and method for using the probes
|
CA2922005A1
(en)
|
2012-09-27 |
2014-04-03 |
Population Diagnostics, Inc. |
Methods and compositions for screening and treating developmental disorders
|
BR112015010035A2
(pt)
|
2012-11-01 |
2017-07-11 |
Infinity Pharmaceuticals Inc |
tratamento de câncer usando moduladores de isoformas quinase pi3
|
US20140272969A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbott Molecular Inc. |
Cell preparations and cell supports and their use in theranosis
|
US9822408B2
(en)
|
2013-03-15 |
2017-11-21 |
Nugen Technologies, Inc. |
Sequential sequencing
|
KR20160013204A
(ko)
|
2013-05-30 |
2016-02-03 |
인피니티 파마슈티칼스, 인코포레이티드 |
Pi3 키나아제 동형단백질 조절제를 사용하는 암의 치료
|
EP2813571A1
(de)
|
2013-06-13 |
2014-12-17 |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Verfahren zur Behandlung von Lungenkrebs
|
US11104950B2
(en)
|
2013-09-11 |
2021-08-31 |
The Regents Of The University Of California |
Human blood molecular biodosimeter panel for distinguishing radiation exposure from inflammation stress
|
EP3511422B1
(de)
|
2013-11-12 |
2022-12-28 |
Population Bio, Inc. |
Verfahren und zusammensetzungen zur diagnose, prognose und behandlung von endometriose
|
EP3068883B1
(de)
|
2013-11-13 |
2020-04-29 |
Nugen Technologies, Inc. |
Zusammensetzungen und verfahren zur identifizierung einer duplikatsequenzierungslesung
|
CA3206268A1
(en)
|
2013-12-06 |
2015-06-11 |
Celgene Corporation |
Methods for determining drug efficacy for the treatment of diffuse large b-cell lymphoma, multiple myeloma, and myeloid cancers
|
US9745614B2
(en)
|
2014-02-28 |
2017-08-29 |
Nugen Technologies, Inc. |
Reduced representation bisulfite sequencing with diversity adaptors
|
EP3134546A4
(de)
|
2014-04-24 |
2017-12-06 |
Dana-Farber Cancer Institute, Inc. |
Tumorsuppressor und onkogene biomarker zur vorhersage der anti-immun-checkpoint-inhibitorreaktion
|
EP3827836A1
(de)
|
2014-06-27 |
2021-06-02 |
Celgene Corporation |
Zusammensetzungen und verfahren zur induktion von konformationsänderungen bei cereblon und anderen e3-ubiquitin-ligasen
|
US9994912B2
(en)
|
2014-07-03 |
2018-06-12 |
Abbott Molecular Inc. |
Materials and methods for assessing progression of prostate cancer
|
GB2558326B
(en)
|
2014-09-05 |
2021-01-20 |
Population Bio Inc |
Methods and compositions for inhibiting and treating neurological conditions
|
AU2015328411C1
(en)
|
2014-10-06 |
2022-03-03 |
Dana-Farber Cancer Institute, Inc. |
Angiopoietin-2 biomarkers predictive of anti-immune checkpoint response
|
CA2963602A1
(en)
|
2014-10-09 |
2016-04-14 |
Dana-Farber Cancer Institute, Inc. |
Multiple-variable il-2 dose regimen for treating immune disorders
|
EP3218482A4
(de)
|
2014-11-11 |
2018-05-09 |
Abbott Molecular Inc. |
Hybridisierungssonden und verfahren
|
WO2016144673A1
(en)
|
2015-03-06 |
2016-09-15 |
Dana-Farber Cancer Institute, Inc. |
Pd-l2 biomarkers predictive of pd-1 pathway inhibitor responses in esophagogastric cancers
|
ES2702603T3
(es)
*
|
2015-06-23 |
2019-03-04 |
Zytovision Gmbh |
Procedimiento para la detección de aberraciones cromosómicas
|
RS62709B1
(sr)
|
2015-08-17 |
2022-01-31 |
Kura Oncology Inc |
Postupci za lečenje pacijenata obolelih od kancera pomoću inhibitora farneziltransferaze
|
US10830762B2
(en)
|
2015-12-28 |
2020-11-10 |
Celgene Corporation |
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
|
KR20180095094A
(ko)
|
2016-01-08 |
2018-08-24 |
셀진 코포레이션 |
암을 치료하기 위한 방법 및 치료요법에 대한 임상 감수성의 예측변수로서 바이오마커의 용도
|
US20190119758A1
(en)
|
2016-04-22 |
2019-04-25 |
Kura Oncology, Inc. |
Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
|
EP3515559A4
(de)
|
2016-09-20 |
2020-07-15 |
Dana-Farber Cancer Institute, Inc. |
Zusammensetzungen und verfahren zur identifizierung, beurteilung, prävention und behandlung von aml mit usp10-biomarkern und modulatoren
|
RS61745B1
(sr)
|
2016-11-03 |
2021-05-31 |
Kura Oncology Inc |
Inhibitori farneziltransferaze za upotrebu u tretiranju kancera
|
EP3577459A4
(de)
|
2017-02-03 |
2020-12-16 |
Celgene Corporation |
Verfahren zur messung der affinität kleiner moleküle gegenüber cereblon
|
US10240205B2
(en)
|
2017-02-03 |
2019-03-26 |
Population Bio, Inc. |
Methods for assessing risk of developing a viral disease using a genetic test
|
US10137121B2
(en)
|
2017-02-21 |
2018-11-27 |
Kura Oncology, Inc. |
Methods of treating cancer with farnesyltransferase inhibitors
|
KR102003179B1
(ko)
|
2017-02-21 |
2019-07-23 |
쿠라 온콜로지, 인크. |
파르네실트랜스퍼라제 억제제를 사용하는 암 환자의 치료 방법
|
EP3634496A4
(de)
|
2017-06-06 |
2021-09-08 |
Dana-Farber Cancer Institute, Inc. |
Verfahren zur sensibilisierung von krebszellen gegen t-zell-vermittelte abtötung mittels modulierung von molekularen signalwegen
|
WO2019032489A1
(en)
|
2017-08-07 |
2019-02-14 |
Kura Oncology, Inc. |
METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS
|
US10806730B2
(en)
|
2017-08-07 |
2020-10-20 |
Kura Oncology, Inc. |
Methods of treating cancer with farnesyltransferase inhibitors
|
US11099202B2
(en)
|
2017-10-20 |
2021-08-24 |
Tecan Genomics, Inc. |
Reagent delivery system
|
WO2019125184A1
(en)
|
2017-12-19 |
2019-06-27 |
Auckland Uniservices Limited |
Use of biomarker in cancer therapy
|
AU2019272751B2
(en)
|
2018-05-23 |
2024-08-15 |
Celgene Corporation |
Treating multiple myeloma and the use of biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1- oxoisoindolin-4-yl)oxy)methyl)benzyl) piperazin-1-yl)-3-fluorobenzonitrile
|
DE24173683T1
(de)
|
2018-08-08 |
2024-11-07 |
Pml Screening, Llc |
Verfahren zur beurteilung des risikos der entwicklung einer viruserkrankung unter verwendung eines genetischen tests
|
CN113286591A
(zh)
|
2018-11-01 |
2021-08-20 |
库拉肿瘤学公司 |
用法尼基转移酶抑制剂治疗癌症的方法
|
US20220142983A1
(en)
|
2019-03-01 |
2022-05-12 |
Kura Oncology, Inc. |
Methods of treating cancer with farnesyltransferase inhibitors
|
WO2020205486A1
(en)
|
2019-03-29 |
2020-10-08 |
Kura Oncology, Inc. |
Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors
|
US20220168296A1
(en)
|
2019-04-01 |
2022-06-02 |
Kura Oncology, Inc. |
Methods of treating cancer with farnesyltransferase inhibitors
|
EP3962529A4
(de)
|
2019-04-30 |
2023-11-01 |
Dana-Farber Cancer Institute, Inc. |
Verfahren zur krebsbehandlung unter verwendung von kombinationen aus anti-cx3cr1 und immuncheckpoint-blockierungsreagenzien
|
US20220305001A1
(en)
|
2019-05-02 |
2022-09-29 |
Kura Oncology, Inc. |
Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors
|
US12059674B2
(en)
|
2020-02-03 |
2024-08-13 |
Tecan Genomics, Inc. |
Reagent storage system
|
US20240083995A1
(en)
|
2021-03-02 |
2024-03-14 |
Laurie H. Glimcher |
Methods of treating red blood cell disorders
|
WO2022261183A2
(en)
|
2021-06-08 |
2022-12-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating and/or identifying an agent for treating intestinal cancers
|
EP4440594A2
(de)
|
2021-11-29 |
2024-10-09 |
Dana-Farber Cancer Institute, Inc. |
Verfahren und zusammensetzungen zur modulierung von riok2
|
WO2023201348A1
(en)
|
2022-04-15 |
2023-10-19 |
Celgene Corporation |
Methods for predicting responsiveness of lymphoma to drug and methods for treating lymphoma
|